Serum concentrations of erlotinib at a dose of 25 mg daily

by Costa, D.B., Kobayashi, S., Yeo, W.-L., Hamada, A.
Published 2014

BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations

by Costa D.B., Halmos B., Kumar A., Schumer S.T., Huberman M.S., Boggon T.J., Tenen D.G., Kobayashi S.
Published 2018

Apoptosis induced by JAK2 inhibition is mediated by Bim and enhanced by the BH3 mimetic ABT-737 in JAK2 mutant human erythroid cells

by Will, B., Siddiqi, T., Jorda, M.A., Luptakova, K., Staber, P.B., Costa, D.B., Kobayashi, S., Steidl, U., Tenen, D.G., Shimamura, T.
Published 2011

Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations

by Yeo, W.-L., Lau, M.W., Warner, J.L., Bodio, K., Huberman, M.S., Tenen, D.G., Kobayashi, S., Costa, D.B., Riely, G.J., Kris, M.G., Yeap, B.Y., Pao, W.
Published 2011

Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer

by Yasuda, H., Park, E., Yun, C.-H., Sng, N.J., Lucena-Araujo, A.R., Yeo, W.-L., Huberman, M.S., Cohen, D.W., Nakayama, S., Ishioka, K., Yamaguchi, N., Hanna, M., Oxnard, G.R., Lathan, C.S., Moran, T., Sequist, L.V., Chaft, J.E., Riely, G.J., Arcila, M.E., Soo, R.A., Meyerson, M., Eck, M.J., Kobayashi, S.S., Costa, D.B.
Published 2014